Mitral valve replacement and closure of ventricular septal defect in the first two months of life

T. Tanaka*, M. Yamaguchi, H. Ohashi, M. Imai, Y. Ohshima, N. Yoshimura, M. Aoyama, K. Ogawa, K. Kuroe, T. Tei, H. Mito

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

A 2-month-old female infant weighing 4.2 kg was admitted with severe congestive heart failure and respiratory distress. The patient was operated upon under a diagnosis of severe congenital mitral regurgitation and ventricular septal defect. There was thickening of the anterior leaflet and short thickened chordae. The valve was judged not amenable to repair and it was replaced with a 17 mm St. Jude Medical valve. She was extubated on the 5th postoperative day. Post operative anti-coagulant therapy was initiated with warfarin potassium, dipyridamole and ticlopidine hydrochloride. The postoperative course was uneventful and the patient is doing well 9 months after the operation.

Original languageEnglish
Pages (from-to)577-579
Number of pages3
JournalKyobu geka. The Japanese journal of thoracic surgery
Volume50
Issue number7
StatePublished - 1997/07

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Mitral valve replacement and closure of ventricular septal defect in the first two months of life'. Together they form a unique fingerprint.

Cite this